{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:29:35Z","timestamp":1790393375386,"version":"4.1.0"},"reference-count":72,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2016.00195","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T03:07:45Z","timestamp":1478574465000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases"],"prefix":"10.3389","volume":"7","author":[{"given":"Ulises","family":"G\u00f3mez-Pinedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio N.","family":"Villar-Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi A.","family":"Mat\u00edas-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Benito-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Guerrero-Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Moreno-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mat\u00edas-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"B1","first-page":"368","article-title":"Descriptive epidemiology of amyotrophic lateral sclerosis","volume":"22","author":"Matias-Guiu","year":"2007","journal-title":"Neurologia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awh132","article-title":"Cortical selective vulnerability in motor neuron disease: a morphometric study","volume":"127","author":"Maekawa","year":"2004","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-007-0226-5","article-title":"TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease","volume":"114","author":"Kwong","year":"2007","journal-title":"Acta Neuropathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1001\/archneur.64.10.1388","article-title":"TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis","volume":"64","author":"Neumann","year":"2007","journal-title":"Arch Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/brain\/104.2.217","article-title":"Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review","volume":"104","author":"Hudson","year":"1981","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/BF00686799","article-title":"Motor neuron disease, parkinsonism and dementia. Report of a case with diffuse Lewy body-like intracytoplasmic inclusions","volume":"75","author":"Delisle","year":"1987","journal-title":"Acta Neuropathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/S0317167100029942","article-title":"Association between Alzheimer disease and amyotrophic lateral sclerosis?","volume":"17","author":"Frecker","year":"1990","journal-title":"Can J Neurol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1017\/S0317167100030729","article-title":"Association between Alzheimer disease and amyotrophic lateral sclerosis?","volume":"17","author":"Sadovnick","year":"1990","journal-title":"Can J Neurol Sci"},{"key":"B12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000116962","article-title":"Amyotrophic lateral sclerosis and frontal lobe dementia in Alzheimer\u2019s disease. Case report and review of the literature","volume":"33","author":"M\u00fcller","year":"1993","journal-title":"Eur Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0022-510X(94)00222-A","article-title":"Concurrence of Alzheimer\u2019s disease, Parkinson\u2019s disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis","volume":"128","author":"Hedera","year":"1995","journal-title":"J Neurol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5692\/clinicalneurol.54.325","article-title":"An autopsy case of frontotemporal lobar degeneration with motor neuron disease associated with numerous diffuse plaques, pretangles and neuropil threads [abstract]","volume":"54","author":"Aoki","year":"2014","journal-title":"Rinsho Shinkeigaku"},{"key":"B15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000331859","article-title":"Amnesia in frontotemporal dementia with amyotrophic lateral sclerosis, masquerading Alzheimer\u2019s disease","volume":"3","author":"Yamanami-Irioka","year":"2011","journal-title":"Case Rep Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1468-1331.2007.01759.x","article-title":"Amyotrophic lateral sclerosis and Alzheimer\u2019s disease-clinical and neuropathological considerations in two cases","volume":"14","author":"Rusina","year":"2007","journal-title":"Eur J Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/WAD.0b013e31821cc65d","article-title":"Adult polyglucosan body disease masquerading as \u201cALS with dementia of the Alzheimer type\u201d: an exceptional phenotype in a rare pathology","volume":"26","author":"Segers","year":"2012","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"B18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/archneur.1979.00500450086021","article-title":"Presenile dementia with motor neuron disease in Japan. A new entity?","volume":"36","author":"Mitsuyama","year":"1979","journal-title":"Arch Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-004-0843-1","article-title":"Alzheimer disease pathology in amyotrophic lateral sclerosis","volume":"107","author":"Hamilton","year":"2004","journal-title":"Acta Neuropathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000433581","article-title":"An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies","volume":"15","author":"Coan","year":"2015","journal-title":"Neurodegener Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/brain\/awm065","article-title":"TDP-43 is deposited in the Guam parkinsonism-dementia complex brains","volume":"130","author":"Hasegawa","year":"2007","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00401-007-0257-y","article-title":"Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam","volume":"115","author":"Geser","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.conb.2015.10.009","article-title":"An amyloid-like cascade hypothesis for C9orf72 ALS\/FTD","volume":"36","author":"Edbauer","year":"2015","journal-title":"Curr Opin Neurobiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci Transl Med"},{"key":"B26","first-page":"354","article-title":"Development of a clinical pathway for the attention of patients with amyotrophic lateral sclerosis in a regional network. ALS Assistance Network-Comunidad de Madrid","volume":"22","author":"Rodr\u00edguez de Rivera","year":"2007","journal-title":"Neurologia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0022-510X(99)00209-9","article-title":"Consensus guidelines for the design and implementation in clinical trials in ALS. World Federation of Neurology Committee on Research","volume":"169","author":"Miller","year":"1999","journal-title":"J Neurol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/21678421.2015.1049183","article-title":"A revision of the El Escorial criteria \u2013 2015","volume":"16","author":"Ludolph","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nrl.2011.02.011","article-title":"SOD1-N196 mutation in a family with amyotrophic lateral sclerosis","volume":"27","author":"Vela","year":"2012","journal-title":"Neurologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: beyond amyloid","volume":"1","author":"Zheng","year":"2006","journal-title":"Mol Neurodegener"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nn.2433","article-title":"Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses","volume":"12","author":"Abramov","year":"2009","journal-title":"Nat Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cellsig.2011.10.007","article-title":"Nuclear signalling by membrane protein intracellular domains: the AICD enigma","volume":"24","author":"Beckett","year":"2012","journal-title":"Cell Signal"},{"issue":"Suppl 1","key":"B34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1471-4159.2011.07475.x","article-title":"The physiology of the \u03b2-amyloid precursor protein intracellular domain AICD","volume":"120","author":"Pardossi-Piquard","year":"2012","journal-title":"J Neurochem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1126\/science.1058783","article-title":"A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60","volume":"293","author":"Cao","year":"2001","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2014.03.075","article-title":"TDP-43 interaction with the intracellular domain of amyloid precursor protein induces p53-associated apoptosis","volume":"569","author":"Wang","year":"2014","journal-title":"Neurosci Lett"},{"key":"B37","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0306-4522(02)00422-0","article-title":"Expression of the Fe65 adapter protein in adult and developing mouse brain","volume":"115","author":"Kesavapany","year":"2002","journal-title":"Neuroscience"},{"key":"B38","doi-asserted-by":"publisher","first-page":"40353","DOI":"10.1074\/jbc.M104059200","article-title":"Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid","volume":"276","author":"Ando","year":"2001","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"33313","DOI":"10.1074\/jbc.M706024200","article-title":"Fe65 stimulates proteolytic liberation of the beta-amyloid precursor protein intracellular domain","volume":"282","author":"Wiley","year":"2007","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1326-7-9","article-title":"FE65 as a link between VLDLR and APP to regulate their trafficking and processing","volume":"7","author":"Dumanis","year":"2012","journal-title":"Mol Neurodegener"},{"key":"B41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1471-4159.2005.03026.x","article-title":"Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load","volume":"93","author":"Santiard-Baron","year":"2005","journal-title":"J Neurochem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"34728","DOI":"10.1074\/jbc.M801874200","article-title":"Dexras1 interacts with FE65 to regulate FE65-amyloid precursor protein-dependent transcription","volume":"283","author":"Lau","year":"2008","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1042\/BJ20141485","article-title":"Phosphorylation of FE65 Ser610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer\u2019s disease amyloid precursor protein processing","volume":"470","author":"Chow","year":"2015","journal-title":"Biochem J"},{"key":"B44","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/oxfordjournals.jbchem.a135662","article-title":"Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer\u2019s disease","volume":"99","author":"Ihara","year":"1986","journal-title":"J Biochem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"B46","doi-asserted-by":"publisher","first-page":"18367","DOI":"10.1073\/pnas.0907652106","article-title":"Alzheimer\u2019s disease-like pathological features in transgenic mice expressing the APP intracellular domain","volume":"106","author":"Ghosal","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1096\/fj.03-0106fje","article-title":"C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression","volume":"17","author":"Kim","year":"2003","journal-title":"FASEB J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.nbd.2005.01.012","article-title":"Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients","volume":"19","author":"Calingasan","year":"2005","journal-title":"Neurobiol Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00702-009-0271-4","article-title":"Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration","volume":"116","author":"Steinacker","year":"2009","journal-title":"J Neural Transm"},{"key":"B50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/mus.20612","article-title":"Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease","volume":"34","author":"Koistinen","year":"2006","journal-title":"Muscle Nerve"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1007\/s11064-004-7037-z","article-title":"Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1","volume":"29","author":"Turner","year":"2004","journal-title":"Neurochem Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1474-9726.2006.00200.x","article-title":"Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model","volume":"5","author":"Li","year":"2006","journal-title":"Aging Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0143420","DOI":"10.1371\/journal.pone.0143420","article-title":"Mutant SOD1 increases APP expression and phosphorylation in cellular and animal models of ALS","volume":"10","author":"Rabinovich-Toidman","year":"2015","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s004010051015","article-title":"Immunoreactivity of beta-amyloid precursor protein in amyotrophic lateral sclerosis","volume":"97","author":"Sasaki","year":"1999","journal-title":"Acta Neuropathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3233\/JAD-2010-091528","article-title":"Severe motor neuron degeneration in the spinal cord of the Tg2576 mouse model of Alzheimer disease","volume":"21","author":"Seo","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1093\/hmg\/dds215","article-title":"Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Bryson","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1016\/j.neurobiolaging.2014.05.035","article-title":"Hippocampal degeneration in patients with amyotrophic lateral sclerosis","volume":"35","author":"Abdulla","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/ene.12615","article-title":"Prose memory impairment in amyotrophic lateral sclerosis patients is related to hippocampus volume","volume":"22","author":"Raaphorst","year":"2015","journal-title":"Eur J Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jns.2007.05.010","article-title":"Memory deficits in amyotrophic lateral sclerosis patients with dementia and degeneration of the perforant pathway: a clinicopathological study","volume":"260","author":"Takeda","year":"2007","journal-title":"J Neurol Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00401-008-0447-2","article-title":"Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease","volume":"117","author":"Takeda","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Ann Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2202-15-74","article-title":"Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain","volume":"15","author":"Spears","year":"2014","journal-title":"BMC Neurosci"},{"issue":"11","key":"B64","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s00259-016-3434-1","article-title":"Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis","volume":"43","author":"Matias-Guiu","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B65","doi-asserted-by":"publisher","first-page":"11560","DOI":"10.1021\/acs.jpcb.5b05964","article-title":"Investigation of the binding profiles of AZD2184 and thioflavin T with amyloid-\u03b2(1-42) fibril by molecular docking and molecular dynamics methods","volume":"119","author":"Kuang","year":"2015","journal-title":"J Phys Chem B"},{"key":"B66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10072-011-0479-6","article-title":"Two cases of dementias with motor neuron disease evaluated by Pittsburgh compound B-positron emission tomography","volume":"33","author":"Yamakawa","year":"2012","journal-title":"Neurol Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/13554794.2012.741252","article-title":"Brain 18F-FDG and 11C-PiB PET findings in two siblings with FTD\/ALS associated with the C9ORF72 repeat expansion","volume":"20","author":"Martikainen","year":"2014","journal-title":"Neurocase"},{"key":"B68","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3233\/JAD-141965","article-title":"Case report of complex amyotrophic lateral sclerosis with cognitive impairment and cortical amyloid deposition","volume":"47","author":"Farid","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","article-title":"Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study","volume":"13","author":"Jack","year":"2014","journal-title":"Lancet Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ene.12851","article-title":"Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression","volume":"23","author":"Blasco","year":"2016","journal-title":"Eur J Neurol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/17482968.2010.541263","article-title":"Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value","volume":"12","author":"Noto","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"B72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2016.00195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T10:35:07Z","timestamp":1568543707000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2016.00195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":72,"URL":"https:\/\/doi.org\/10.3389\/fneur.2016.00195","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}